SCHEMBL6001185

SCHEMBL6001185

C1=C(N(Cc2ccccc2)c2nc(-c3cccs3)cc3ccccc23)OCO1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
KDM4E B2RXH2 8/20 0.36
ALDH1A1 P00352 8/20 0.36
GAA P10253 5/20 0.36
HPGD P15428 6/20 0.35
MAPT P10636 5/20 0.35
LMNA P02545 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
GBA1 P04062 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
GLA P06280 3/20 0.34
HSD17B10 Q99714 2/20 0.34
TP53 P04637 2/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001916 0.85 MEN1 (0.43) MEN1KMT2AKDM4EALDH1A1GAA
SCHEMBL6001383 0.83 ALDH1A1 (0.51) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL6001211 0.80 MAPT (0.40) MEN1KMT2AKDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL5358708 0.71 LMNA (0.35) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL6001427 0.69 ALDH1A1 (0.52) MEN1KMT2AKDM4EALDH1A1GAA
Hydrochloric Acid SCHEMBL5368590 0.68 LMNA (0.34) KDM4EALDH1A1HPGDMAPTLMNA
SCHEMBL6001175 0.67 PDE5A (0.48) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL3639827 0.67 RPS6KB2 (0.32) KDM4EALDH1A1GAASMN1; SMN2NPSR1
SCHEMBL4133791 0.66 SMN1; SMN2 (0.37) SMN1; SMN2
SCHEMBL4904331 0.66 SMN1; SMN2 (0.41) MEN1KMT2AKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060128702-A1 Heterocyclic and bicyclic compounds, compositions and methods REDDY US THERAPEUTICS, INC. 2006-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128702-A1 Heterocyclic and bicyclic compounds, compositions and methods HPSE, ENGASE, UGCG MEN1 2168/4885KMT2A 3343/4885KDM4E 2893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.